agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
92.28
+1.91 (2.11%)
At close: May 29, 2026, 4:00 PM EDT
92.00
-0.28 (-0.30%)
After-hours: May 29, 2026, 7:54 PM EDT
agilon health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 139.99 | 173.71 | 188.23 | 107.57 | 465.3 | 1,040 |
Short-Term Investments | 91.42 | 111.43 | 211.74 | 380.77 | 411.9 | - |
Cash & Short-Term Investments | 231.41 | 285.14 | 399.97 | 488.34 | 877.2 | 1,040 |
Cash Growth | -36.96% | -28.71% | -18.10% | -44.33% | -15.66% | 873.87% |
Accounts Receivable | 899.75 | 673.79 | 1,017 | 942.46 | 492.36 | 293.41 |
Other Current Assets | 190.02 | 137.76 | 40.77 | 49.27 | 81.71 | 33.75 |
Total Current Assets | 1,321 | 1,097 | 1,458 | 1,480 | 1,451 | 1,367 |
Net Property, Plant & Equipment | 24.89 | 25.42 | 28.17 | 27.58 | 19.94 | 9.16 |
Other Intangible Assets | 62.45 | 65.73 | 72.77 | 63.77 | 18.45 | 55.4 |
Goodwill | - | - | 24.13 | 24.13 | 2.51 | 41.54 |
Other Long-Term Assets | 96.43 | 83.45 | 151.14 | 145.31 | 205.3 | 112.96 |
Total Assets | 1,505 | 1,271 | 1,734 | 1,741 | 1,697 | 1,586 |
Accounts Payable | 202.48 | 127.48 | 220.34 | 239.43 | 177.43 | 112.95 |
Accrued Expenses | 1,055 | 929.77 | 931.66 | 737.72 | 300.8 | 239.01 |
Short-Term Debt | - | - | - | - | 5 | 5 |
Current Portion of Long-Term Debt | 14.75 | 19.24 | - | - | - | - |
Other Current Liabilities | - | - | - | - | 51.87 | - |
Total Current Liabilities | 1,272 | 1,076 | 1,152 | 977.16 | 535.09 | 356.96 |
Long-Term Debt | 15.28 | 15.75 | 34.9 | 32.31 | 38.48 | 43.4 |
Other Long-Term Liabilities | 35.9 | 52.32 | 76.12 | 70.38 | 83.29 | 94.3 |
Total Long-Term Liabilities | 51.18 | 68.07 | 111.03 | 102.69 | 121.77 | 137.7 |
Total Liabilities | 1,324 | 1,145 | 1,263 | 1,080 | 656.86 | 494.66 |
Common Stock | 0.17 | 4.15 | 4.12 | 4.06 | 4.12 | 4 |
Additional Paid-in Capital | 2,110 | 2,100 | 2,054 | 1,987 | 2,107 | 2,046 |
Accumulated Other Comprehensive Income | 0.48 | 0.92 | -0.09 | -2.3 | -5.56 | - |
Retained Earnings | - | - | - | -1,327 | -1,064 | -957.68 |
Total Common Shareholders' Equity | 2,111 | 2,105 | 2,058 | 661.84 | 1,041 | 1,092 |
Minority Interest | - | - | - | -0.82 | -0.61 | -0.3 |
Shareholders' Equity | 2,111 | 2,105 | 2,058 | 661.02 | 1,041 | 1,092 |
Total Liabilities & Equity | 1,505 | 1,271 | 1,734 | 1,741 | 1,697 | 1,586 |
Total Debt | 30.03 | 34.99 | 34.9 | 32.31 | 43.48 | 48.4 |
Net Cash (Debt) | 201.39 | 250.15 | 365.06 | 456.04 | 833.72 | 991.64 |
Net Cash Growth | -19.50% | -31.48% | -19.95% | -45.30% | -15.93% | 2436.87% |
Net Cash Per Share | 12.14 | 15.11 | 22.21 | 27.88 | 51.07 | 66.48 |
Book Value | 2,111 | 2,105 | 2,058 | 661.84 | 1,041 | 1,092 |
Book Value Per Share | 127.20 | 127.13 | 125.19 | 40.46 | 63.78 | 73.20 |
Tangible Book Value | 2,048 | 2,039 | 1,961 | 573.94 | 1,020 | 994.96 |
Tangible Book Value Per Share | 123.44 | 123.16 | 119.29 | 35.09 | 62.49 | 66.70 |